REGN vs. QQQ

In the year-to-date period, REGN achieves a -15.16% return, which is significantly lower than QQQ's -4.81% return. Over the past 10 years, REGN has underperformed QQQ with an annualized return of 2.31%, while QQQ has yielded a comparatively higher 17.12% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Regeneron Pharmaceuticals, Inc. (REGN) and Invesco QQQ (QQQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current REGN Sharpe Ratio is -1.11, which is lower than the QQQ Sharpe Ratio of 0.63. The chart below compares the historical Sharpe Ratios of REGN and QQQ, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

REGN's dividend yield for the trailing twelve months is around 0.15%, less than QQQ's 0.62% yield.

The maximum REGN drawdown since its inception was -91.81%, which is greater than QQQ's maximum drawdown of -82.98%. Use the drawdown chart below to compare losses from any high point for REGN and QQQ. For additional features, visit the drawdowns tool.

Regeneron Pharmaceuticals, Inc. (REGN) and Invesco QQQ (QQQ) have volatilities of 15.33% and 15.67%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.